Fresh analysis indicates that patients who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who end traditional lifestyle programs.
Published data in a leading medical journal demonstrates that while obese people can lose substantial amounts of their body weight while using the jabs, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals using these medications must be aware of the potential of fast rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.
That rate of regain implies a return to pre-treatment weight in about one and a half years.
Comparing Therapies
The study, which reviewed 37 of trials involving thousands of participants, contrasted the results of GLP-1 agonists with older methods.
The team emphasize that people who lose weight through diet and exercise typically experience a more gradual weight regain—approximately 100 grams monthly—once they finish.
Explaining the Quick Regain
Experts suggest the mechanism of the injections explains the accelerated regain.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 concentrations far above than normal may cause the system to produce less of its endogenous hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making excessive eating a significant risk."
An Ongoing Issue?
Health authorities suggest the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
Professionals contend that, given the likelihood of relapse, the treatment should be considered ongoing.
This opinion is reinforced by drug manufacturers, who state that the results "underscore the long-term character of obesity," similar to managing diseases like high blood pressure.
Patient Testimonies
People who have stopped the jabs describe a powerful return of hunger.
"It felt as if a switch flipping and you become starving," recalled one woman.
This difficulty is worsened if patients have not adopted sustainable lifestyle or habit changes during treatment.
Widespread Adoption
Figures suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with interest remaining high.
- Use is higher among women than males.
- The 40s and 50s age group shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, researchers caution that while GLP-1 drugs are effective agents for weight loss, they are not a magic fix and lasting health benefits hinges on integrated lifestyle changes.
